Lombard Odier Asset Management (USA)’s NxStage Medical Inc. NXTM Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-220,000	Closed	-$6.3M	–	327
2018 Q4	$6.3M	Buy	220,000 +200,000	+1,000%	+$5.68M	0.5%	65
2018 Q3	$558K	Sell	20,000 -4,200	-17%	-$118K	0.04%	206
2018 Q2	$675K	Buy	+24,200	New	+$649K	0.04%	221
2017 Q3	–	Sell	-123,281	Closed	-$3.09M	–	277
2017 Q2	$3.09M	Buy	123,281 +53,281	+76%	+$1.32M	0.24%	109
2017 Q1	$1.88M	Buy	+70,000	New	+$1.93M	0.18%	135

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s NXTM Position: Q1 2019 in Review

Lombard Odier Asset Management (USA) sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 220,000 shares — an estimated $6.3M sold.

Lombard Odier Asset Management (USA) first reported a position in NXTM in Q1 2017 and held it in 5 quarters. The position peaked at $6.3M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Lombard Odier Asset Management (USA) reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 220,000 NxStage Medical Inc. shares in Q1 2019, an estimated $6.3M.
Lombard Odier Asset Management (USA) first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 5 quarters.
Lombard Odier Asset Management (USA)'s NxStage Medical Inc. position peaked at $6.3M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2019, filed 15 May 2019.